Sonal Sonu/LinkedIn
Feb 14, 2026, 17:18
Sonal Sonu: A Compatible Crossmatch Does Not Guarantee Transfusion Safety
Sonal Sonu, Transfusion Medicine Specialist, posted on LinkedIn:
“A compatible crossmatch confirms serological compatibility at the time of testing – not absolute transfusion safety.
Evanescent alloantibodies and anamnestic immune responses can still result in delayed hemolytic transfusion reactions.
Safe transfusion is not just about reports.
It requires patient history, clinical context, and vigilance.
Transfusion medicine is clinical judgment – not a checkbox.”
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator